Cargando…

Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018

Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sridhar, Siddharth, Cheng, Vincent C.C., Wong, Shuk-Ching, Yip, Cyril C.Y., Wu, Shusheng, Lo, Anthony W.I., Leung, Kit-Hang, Mak, Winger W.N., Cai, Jianpiao, Li, Xin, Chan, Jasper F.W., Lau, Susanna K.P., Woo, Patrick C.Y., Lai, Wai-Ming, Kwan, Tze-Hoi, Au, Timmy W.K., Lo, Chung-Mau, Wong, Sally C.Y., Yuen, Kwok-Yung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390757/
https://www.ncbi.nlm.nih.gov/pubmed/30789146
http://dx.doi.org/10.3201/eid2503.181563
_version_ 1783398204059942912
author Sridhar, Siddharth
Cheng, Vincent C.C.
Wong, Shuk-Ching
Yip, Cyril C.Y.
Wu, Shusheng
Lo, Anthony W.I.
Leung, Kit-Hang
Mak, Winger W.N.
Cai, Jianpiao
Li, Xin
Chan, Jasper F.W.
Lau, Susanna K.P.
Woo, Patrick C.Y.
Lai, Wai-Ming
Kwan, Tze-Hoi
Au, Timmy W.K.
Lo, Chung-Mau
Wong, Sally C.Y.
Yuen, Kwok-Yung
author_facet Sridhar, Siddharth
Cheng, Vincent C.C.
Wong, Shuk-Ching
Yip, Cyril C.Y.
Wu, Shusheng
Lo, Anthony W.I.
Leung, Kit-Hang
Mak, Winger W.N.
Cai, Jianpiao
Li, Xin
Chan, Jasper F.W.
Lau, Susanna K.P.
Woo, Patrick C.Y.
Lai, Wai-Ming
Kwan, Tze-Hoi
Au, Timmy W.K.
Lo, Chung-Mau
Wong, Sally C.Y.
Yuen, Kwok-Yung
author_sort Sridhar, Siddharth
collection PubMed
description Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 transplant recipients. The donor had been viremic but HEV IgM and IgG seronegative, and liver function test results were within reference ranges. After a mean of 52 days after transplantation, hepatitis developed in all 5 recipients; in the liver graft recipient, disease was severe and with progressive portal hypertension. Despite reduced immunosuppression, all HEV-4 infections progressed to persistent hepatitis. Four patients received ribavirin and showed evidence of response after 2 months. This study highlights the role of organ donation in HEV transmission, provides additional data on the natural history of HEV-4 infection, and points out differences between genotype 3 and 4 infections in immunocompromised patients.
format Online
Article
Text
id pubmed-6390757
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-63907572019-03-06 Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018 Sridhar, Siddharth Cheng, Vincent C.C. Wong, Shuk-Ching Yip, Cyril C.Y. Wu, Shusheng Lo, Anthony W.I. Leung, Kit-Hang Mak, Winger W.N. Cai, Jianpiao Li, Xin Chan, Jasper F.W. Lau, Susanna K.P. Woo, Patrick C.Y. Lai, Wai-Ming Kwan, Tze-Hoi Au, Timmy W.K. Lo, Chung-Mau Wong, Sally C.Y. Yuen, Kwok-Yung Emerg Infect Dis Synopsis Hepatitis E virus (HEV) genotype 4 (HEV-4) is an emerging cause of acute hepatitis in China. Less is known about the clinical characteristics and natural history of HEV-4 than HEV genotype 3 infections in immunocompromised patients. We report transmission of HEV-4 from a deceased organ donor to 5 transplant recipients. The donor had been viremic but HEV IgM and IgG seronegative, and liver function test results were within reference ranges. After a mean of 52 days after transplantation, hepatitis developed in all 5 recipients; in the liver graft recipient, disease was severe and with progressive portal hypertension. Despite reduced immunosuppression, all HEV-4 infections progressed to persistent hepatitis. Four patients received ribavirin and showed evidence of response after 2 months. This study highlights the role of organ donation in HEV transmission, provides additional data on the natural history of HEV-4 infection, and points out differences between genotype 3 and 4 infections in immunocompromised patients. Centers for Disease Control and Prevention 2019-03 /pmc/articles/PMC6390757/ /pubmed/30789146 http://dx.doi.org/10.3201/eid2503.181563 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Sridhar, Siddharth
Cheng, Vincent C.C.
Wong, Shuk-Ching
Yip, Cyril C.Y.
Wu, Shusheng
Lo, Anthony W.I.
Leung, Kit-Hang
Mak, Winger W.N.
Cai, Jianpiao
Li, Xin
Chan, Jasper F.W.
Lau, Susanna K.P.
Woo, Patrick C.Y.
Lai, Wai-Ming
Kwan, Tze-Hoi
Au, Timmy W.K.
Lo, Chung-Mau
Wong, Sally C.Y.
Yuen, Kwok-Yung
Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
title Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
title_full Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
title_fullStr Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
title_full_unstemmed Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
title_short Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
title_sort donor-derived genotype 4 hepatitis e virus infection, hong kong, china, 2018
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390757/
https://www.ncbi.nlm.nih.gov/pubmed/30789146
http://dx.doi.org/10.3201/eid2503.181563
work_keys_str_mv AT sridharsiddharth donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT chengvincentcc donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT wongshukching donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT yipcyrilcy donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT wushusheng donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT loanthonywi donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT leungkithang donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT makwingerwn donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT caijianpiao donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT lixin donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT chanjasperfw donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT laususannakp donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT woopatrickcy donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT laiwaiming donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT kwantzehoi donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT autimmywk donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT lochungmau donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT wongsallycy donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018
AT yuenkwokyung donorderivedgenotype4hepatitisevirusinfectionhongkongchina2018